Skip to main content

Lung Cancer

Lung Cancer
My Practice: Roles and Responsibilities
Read More
Lung Cancer
Challenges in Managing Toxicities
Read More
Lung Cancer
Nivolumab plus Ipilimumab Combination Promotes Durable Responses in Advanced Lung Cancer
Read More
Lung Cancer
Alectinib Potential First-Line Treatment for NSCLC Associated with ALK Mutation
Read More
In the News, Lung Cancer
New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation
Lilly Ostrovsky
Read More
Lung Cancer
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
Read More
Lung Cancer
Ramucirumab Shows Survival Benefit in NSCLC
Read More
Lung Cancer
Crizotinib Superior to Standard Chemotherapy in ALK-Positive Lung Cancer
Read More
Lung Cancer
Current Treatment of Advanced NSCLC Requires Testing for Driver Mutations
Read More
Lung Cancer
Afatinib Doubles Progression-Free Survival Compared with Chemotherapy in Patients with Lung Cancer
Read More
Page 4 of 5
Results 31 - 40 of 44